METTL3 and familial pancreatic carcinoma: METTL3 expression may induce resistance to chemotherapy as METTL3 knockdown increased sensitivity to gemcitabine, 5-fluorouracil (5-FU) and cisplatin in pancreatic cancer, potentially through activation of MAPK signaling [38].